Casdozokitug Biosimilar – Anti-p28 mAb – Research Grade from ProteoGenix; catalogue PX-TA2053; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Casdozokitug Biosimilar is a research grade antibody that specifically targets the protein p28. This biosimilar is a monoclonal antibody, or mAb, which means it is produced by a single clone of cells and is highly specific for its target.
The Casdozokitug Biosimilar is a recombinant antibody, meaning it is produced through genetic engineering techniques. It is composed of two heavy chains and two light chains, held together by disulfide bonds. The variable regions of the antibody, which are responsible for binding to the target protein, are located at the tips of the heavy and light chains.
The main activity of Casdozokitug Biosimilar is its ability to bind to the protein p28 with high specificity and affinity. This binding prevents the protein from carrying out its normal function, which may be important in disease processes. The binding of Casdozokitug Biosimilar to p28 also triggers an immune response, leading to the destruction of cells expressing the target protein.
Casdozokitug Biosimilar has potential applications in both research and therapeutic settings. In research, it can be used as a tool to study the function of p28 and its role in various diseases. It can also be used to detect the presence of p28 in samples, such as tissue or blood, through techniques like immunohistochemistry or ELISA.
In a therapeutic context, Casdozokitug Biosimilar can be used as a treatment for diseases where p28 plays a role. This includes autoimmune diseases, inflammatory disorders, and certain types of cancer. By targeting and neutralizing p28, Casdozokitug Biosimilar can help alleviate symptoms and improve patient outcomes.
Casdozokitug Biosimilar – Anti-p28 mAb – Research Grade is a highly specific and effective antibody that targets the protein p28. Its recombinant structure and ability to trigger an immune response make it a valuable tool in both research and therapeutic applications. With further research and development, Casdozokitug Biosimilar has the potential to make a significant impact in the treatment of various diseases.
Antibody, therapeutic target, Casdozokitug Biosimilar, Anti-p28 mAb, research grade, protein p28, monoclonal antibody, recombinant, specificity, affinity, immune response, research, therapeutic, autoimmune diseases, inflammatory disorders, cancer.
ProteoGenix catalogue number PX-TA2053. For research use only.
Target: Casdozokitug Biosimilar – Anti-p28 mAb – Research Grade; Clonality: Monoclonal Antibody; Expression system: XtenCHO; Purity: >90% by SDS-PAGE.; Buffer: 0.01M PBS, pH 7.4.; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Casdozokitug Biosimilar – Anti-p28 mAb – Research Grade |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
